Publications
Explore 634 academic publications
ShinyGO: a graphical gene-set enrichment tool for animals and plants
Abstract Motivation Gene lists are routinely produced from various omic studies. Enrichment analysis can link these gene lists with underlying molecular pathways and functional ...
Environmental and Health Impacts of Air Pollution: A Review
One of our era's greatest scourges is air pollution, on account not only of its impact on climate change but also its impact on public and individual health due to increasing mo...
miRBase: from microRNA sequences to function
This FAIRsharing record describes: The miRBase database is a searchable database of published miRNA sequences and annotation. Each entry in miRBase represents a predicted hairpi...
The EMBL-EBI search and sequence analysis tools APIs in 2019
Abstract The EMBL-EBI provides free access to popular bioinformatics sequence analysis applications as well as to a full-featured text search engine with powerful cross-referenc...
Breast Cancer Treatment
Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct...
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality.
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly d...
Trastuzumab-Induced Hepatotoxicity: A Case Report
<b><i>Background: </i></b>Trastuzumab is a humanized monoclonal antibody approved for the treatment of breast cancer with HER2 amplification and/or overe...
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...